logo
Plus   Neg
Share
Email

Stock Alert: Enlivex Therapeutics Rise Continues

Shares of Enlivex Therapeutics Ltd. (ENLV) are up more than 30% Monday morning, continuing the momentum following positive Covid-19 drug results.

On October 1, the company had reported positive top-line results from the study of its Covid-19 drug candidate, Allocetra.

The stock gained nearly 60% in the last two days.

Enlivex stock is currently trading at $14.12, nearing to its 52-week high of $16.94.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
RELATED NEWS
Follow RTT